18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Natural killer (NK) cells are innate lymphocytes that play essential roles in mediating antitumor immunity. NK cells respond to various inflammatory stimuli including cytokines and stress-induced cellular ligands which activate germline-encoded activation receptors (NKRs), such as NKG2D. The signaling molecules activated downstream of NKRs are well defined; however, the mechanisms that regulate these pathways are not fully understood. IQ domain-containing GTPase-activating protein 1 (IQGAP1) is a ubiquitously expressed scaffold protein. It regulates diverse cellular signaling programs in various physiological contexts, including immune cell activation and function. Therefore, we sought to investigate the role of IQGAP1 in NK cells. Development and maturation of NK cells from mice lacking IQGAP1 ( Iqgap1 −/− ) were mostly intact; however, the absolute number of splenic NK cells was significantly reduced. Phenotypic and functional characterization revealed a significant reduction in the egression of NK cells from the bone marrow of Iqagp1 −/− mice altering their peripheral homeostasis. Lack of IQGAP1 resulted in reduced NK cell motility and their ability to mediate antitumor immunity in vivo. Activation of Iqgap1 −/− NK cells via NKRs, including NKG2D, resulted in significantly reduced levels of inflammatory cytokines compared with wild-type (WT). This reduction in Iqgap1 −/− NK cells is neither due to an impaired membrane proximal signaling nor a defect in gene transcription. The levels of Ifng transcripts were comparable between WT and Iqgap1 −/− , suggesting that IQGAP1-dependent regulation of cytokine production is regulated by a post-transcriptional mechanism. To this end, Iqgap1 −/− NK cells failed to fully induce S6 phosphorylation and showed significantly reduced protein translation following NKG2D-mediated activation, revealing a previously undefined regulatory function of IQGAP1 via the mechanistic target of rapamycin complex 1. Together, these results implicate IQGAP1 as an essential scaffold for NK cell homeostasis and function and provide novel mechanistic insights to the post-transcriptional regulation of inflammatory cytokine production.

          Related collections

          Most cited references77

          • Record: found
          • Abstract: found
          • Article: not found

          Fueling immunity: insights into metabolism and lymphocyte function.

          Lymphocytes face major metabolic challenges upon activation. They must meet the bioenergetic and biosynthetic demands of increased cell proliferation and also adapt to changing environmental conditions, in which nutrients and oxygen may be limiting. An emerging theme in immunology is that metabolic reprogramming and lymphocyte activation are intricately linked. However, why T cells adopt specific metabolic programs and the impact that these programs have on T cell function and, ultimately, immunological outcome remain unclear. Research on tumor cell metabolism has provided valuable insight into metabolic pathways important for cell proliferation and the influence of metabolites themselves on signal transduction and epigenetic programming. In this Review, we highlight emerging concepts regarding metabolic reprogramming in proliferating cells and discuss their potential impact on T cell fate and function.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Up on the tightrope: natural killer cell activation and inhibition.

            Natural killer (NK) cells circulate through the blood, lymphatics and tissues, on patrol for the presence of transformed or pathogen-infected cells. As almost all NK cell receptors bind to host-encoded ligands, signals are constantly being transmitted into NK cells, whether they interact with normal or abnormal cells. The sophisticated repertoire of activating and inhibitory receptors that has evolved to regulate NK cell activity ensures that NK cells protect hosts against pathogens, yet prevents deleterious NK cell-driven autoimmune responses. Here I highlight recent advances in our understanding of the structural properties and signaling pathways of the inhibitory and activating NK cell receptors, with a particular focus on the ITAM-dependent activating receptors, the NKG2D-DAP10 receptor complexes and the CD244 receptor system.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Maturation of mouse NK cells is a 4-stage developmental program.

              Surface density of CD27 and CD11b subdivides mouse natural killer (NK) cells into 4 subsets: CD11b(low)CD27(low), CD11b(low)CD27(high), CD11b(high)CD27(high), and CD11b(high)CD27(low). To determine the developmental relationship between these 4 subsets, we used several complementary approaches. First, we took advantage of NDE transgenic mice that express enhanced green fluorescent protein (EGFP) and diphtheria toxin receptor specifically in NK cells. Diphtheria toxin injection leads to a transient depletion of NK cells, allowing the monitoring of the phenotype of developing EGFP+ NK cells after diphtheria toxin injection. Second, we evaluated the overall proximity between NK-cell subsets based on their global gene profile. Third, we compared the proliferative capacity of NK-cell subsets at steady state or during replenishment of the NK-cell pool. Fourth, we performed adoptive transfers of EGFP+ NK cell subsets from NDE mice into unirradiated mice and followed the fate of transferred cells. The results of these various experiments collectively support a 4-stage model of NK-cell maturation CD11b(low)CD27(low) --> CD11b(low)CD27(high) --> CD11b(high)CD27(high) --> CD11b(high)CD27(low). This developmental program appears to be associated with a progressive acquisition of NK-cell effector functions.
                Bookmark

                Author and article information

                Contributors
                URI : https://frontiersin.org/people/u/255068
                URI : https://frontiersin.org/people/u/30467
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                28 May 2018
                2018
                : 9
                : 1168
                Affiliations
                [1] 1Department of Microbiology and Immunology, Medical College of Wisconsin , Milwaukee, WI, United States
                [2] 2Laboratory of Molecular Immunology and Immunotherapy, Blood Research Institute , Milwaukee, WI, United States
                [3] 3Department of Pediatrics, Medical College of Wisconsin , Milwaukee, WI, United States
                [4] 4Department of Medicine, Medical College of Wisconsin , Milwaukee, WI, United States
                Author notes

                Edited by: Silke Paust, Baylor College of Medicine, United States

                Reviewed by: Michael Diehl, Rice University, United States; Jennifer Ann Foltz, The Research Institute at Nationwide Children’s Hospital, United States

                *Correspondence: Subramaniam Malarkannan, Subra.malar@ 123456bcw.edu

                Specialty section: This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology

                Article
                10.3389/fimmu.2018.01168
                5985319
                6cfaf70b-f8ab-4834-a472-4f2df2fd1f52
                Copyright © 2018 Abel, Tiwari, Gerbec, Siebert, Yang, Schloemer, Dixon, Thakar and Malarkannan.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 11 March 2018
                : 09 May 2018
                Page count
                Figures: 8, Tables: 0, Equations: 0, References: 91, Pages: 17, Words: 12117
                Funding
                Funded by: National Institutes of Health 10.13039/100000002
                Award ID: AI102893, A1064826
                Funded by: National Cancer Institute 10.13039/100000054
                Award ID: CA179363
                Funded by: Midwest Athletes Against Childhood Cancer
                Funded by: American Cancer Society 10.13039/100000048
                Funded by: Alex’s Lemonade Stand Foundation for Childhood Cancer 10.13039/100001445
                Funded by: Ann’s Hope Foundation
                Funded by: Nicholas Family Foundation
                Funded by: Nan Gardetto Family Foundation
                Funded by: HRHM
                Categories
                Immunology
                Original Research

                Immunology
                iq domain-containing gtpase-activating protein 1,natural killer cells,cytoskeleton,nkg2d,ifn-γ,translation,mechanistic target of rapamycin,ribosomal protein s6

                Comments

                Comment on this article